🟢 Veracyte is trading 5% up in after-hours trading with no clear catalyst

Veracyte is trading 4.89% higher at $46.35 after-hours, with no clear catalyst identified for the rebound.

• The stock closed at $44.19 on October 1, 2026, after declining 4.02% in the regular session.
• Recent company coverage highlighted prostate cancer trial findings and planned ASTRO presentations, but no source linked them to the after-hours move.
• The broader market was mixed and offered no clear explanation for the rise.